# AZACITIDINE
> **ANDA209540** · Abbreviated New Drug Application (Generic) · Sponsor: CIPLA · Approved 2018-05-04
## Drug
- **FDA Application Number:** ANDA209540
- **Application type:** Abbreviated New Drug Application (Generic)
- **Brand name:** AZACITIDINE
- **Generic name:** Azacitidine
- **Active ingredients:** AZACITIDINE
- **Dosage form:** POWDER
- **Route:** INTRAVENOUS, SUBCUTANEOUS
- **Marketing status:** Prescription
- **Sponsor:** CIPLA
- **First approval:** 2018-05-04
## Source
- [Drugs@FDA application overview](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=209540)
---
*AI Analytics · CC0 1.0*